TLC to Present as Panelist among Key Opinion Leaders at the BTIG Pain Management Forum
September 03, 2019 06:04 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 03, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152) announced today that the Company’s management team has been invited to participate in...
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
August 28, 2019 07:45 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic...
Endonovo Therapeutics Announces Second Quarter Results
August 13, 2019 13:39 ET
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the...
In vivo CRO Market To Reach USD 5786.4 Million By 2026 | Reports And Data
July 29, 2019 09:27 ET
|
Reports and Data
New York, July 29, 2019 (GLOBE NEWSWIRE) -- High prevalence of target diseases, immense funding for carrying out R&D activities, increasing strategic developments such as partnerships and...
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
July 09, 2019 08:00 ET
|
BioDelivery Sciences International, Inc.
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.S. RALEIGH, N.C., July 09, 2019 (GLOBE...
BioDelivery Sciences Expands Upon Report from Pain Management Task Force
June 24, 2019 08:00 ET
|
BioDelivery Sciences International, Inc.
Company’s Activities Support Buprenorphine Recommendations Including: Primary Use of Buprenorphine in Chronic Pain when Clinically IndicatedHaving Payers Provide Coverage and Reimbursement for...
Trevena Announces Publication of APOLLO-2 Results in Pain Practice
June 24, 2019 07:00 ET
|
Trevena Inc.
CHESTERBROOK, Pa., June 24, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
BioDelivery Sciences Named to the Russell 3000® Index
June 20, 2019 08:00 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is set to be added to the broad-market Russell 3000® Index as well as the Russell 2000® Index...
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
May 28, 2019 16:10 ET
|
BioDelivery Sciences International, Inc.
New Agreement is Cash Flow Accretive, Lowers Cost of Capital and Extends Debt Maturity Reduces Annual Interest Costs by Approximately $1.5 million Increases Flexibility to Continue Growth Trajectory...
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation
May 09, 2019 10:11 ET
|
MilanaPharm
TALLASSEE, Ala., May 09, 2019 (GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management...